Healthcare
Ebola Drug Remdesivir Shows Early Signs Of Hope In Treating COVID Patients
A drug used to treat Ebola patients, Redesivir, is showing signs of hope against the COVID-19 virus in early trials, according to a press release from biopharmaceutical company Gilead Sciences.
The drug is also used for Marburg, MERS and SARS viruses.
“Unlike traditional drug development, we are attempting to evaluate an investigational agent alongside an evolving global pandemic. Multiple concurrent studies are helping inform whether remdesivir is a safe and effective treatment for COVID-19 and how to best utilize the drug,” said Merdad Parsey, MD, PhD, Chief Medical Officer, Gilead Sciences in a statement released Wednesday.
The statement continued, “These study results complement data from the placebo-controlled study of remdesivir conducted by the National Institute for Allergy and Infectious Diseases and help to determine the optimal duration of treatment with remdesivir. The study demonstrates the potential for some patients to be treated with a 5-day regimen, which could significantly expand the number of patients who could be treated with our current supply of remdesivir. This is particularly important in the setting of a pandemic, to help hospitals and healthcare workers treat more patients in urgent need of care.”
The trial found that patients who received a 5-day dosage of the medication showed similar signs of improvement compared to a 10-day dosage. More than half of the patients treated early on in their diagnosis were discharged from the hospital before 14 days, according to the release.

Healthcare
Nebraska woman who detransitioned sues doctors who facilitated removal of ‘healthy breasts’ when she was a teen battling mental health

Nebraska woman Luka Hein is suing Nebraska Medicine, the Nebraska Medical Center, and University of Nebraska Medical Center (UNMC) Physicians who facilitated in her gender transition when she was a teenager; Hein has since detransitioned.
Hein, who is being represented by the Center for American Liberty, filed the suit last week, for removal of her healthy breasts when she was a depressed teenager who struggled with mental health.
“Proceeding straight to breast amputation in a depressed, anxiety-ridden, gender-confused adolescent, who was incapable of understanding the lasting consequences of her decision, constitutes negligence for which Defendants are jointly and severally liable,” the lawsuit states.
Fox News reports:
Throughout adolescence, Hein struggled with her mental health and traumatic experiences, including being allegedly groomed and threatened by an adult man. She had serious mental-health struggles at age 13. By 15 she was diagnosed with “gender identity disorder” and put on a fast track to have her breasts removed, according to the lawsuit.
The lawsuit claims that despite Hein’s history, doctors rushed her into gender transition without considering her psychological comorbidities. It says the defendants used deceptive euphemisms and unscientific terminology to sell gender-transition procedures to Hein.
For instance, their use of the phrase “masculinizing hormone therapy” was misleading as the process does not heal the patient but does “inflict harm that causes malfunctioning and malformation of the teenage body and brain,” according to the lawsuit. Testosterone injections, which Hein received as part of her attempted sex change, can cause many negative side effects including high blood pressure and permanent bodily changes such as the development of an Adam’s apple, deepening of the voice, abnormal hair growth, and male pattern balding of the scalp.
The lawsuit says defendants were also negligent in other ways, such as in their shifting from a standard medical diagnosis to the “affirming care” model, which embraces a person’s gender delusion as fact and discourages questioning.
Allegedly one doctor, Nahia J. Amoura, was prepared to go even further. “About a year after starting Luka on testosterone, Dr. Amoura recommended to Luka that she surgically remove her uterus in a partial hysterectomy as the next step in her ‘transition,’” the lawsuit states. The hysterectomy would have permanently sterilized Hein and created hormonal imbalances that would have required long-term medical follow-ups.
-
China7 days ago
Electric Vehicle company with Chinese ties awarded $500 million of taxpayer money for 2nd U.S. plant
-
War on Drugs4 days ago
Kilo of fentanyl found on children’s mats at Bronx daycare, 4 children overdosed, 1 year old boy dies
-
War on Drugs4 days ago
Children under 14 dying from fentanyl poisoning at ‘faster rate than any other age group’
-
Healthcare7 days ago
Nebraska woman who detransitioned sues doctors who facilitated removal of ‘healthy breasts’ when she was a teen battling mental health